Mehran Jalaie

This inventor holds 15 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 4 EPO patents, primarily in Cancer Therapeutics. Top assignee: Pfizer Corporation. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mehran Jalaie. Retrieved from https://idiyas.com/inventor/mehran-jalaie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 9)

% Patents Active = 86.7

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 9.6

ph-index = 2

Forward Citations = 11(Granted Patents)

Company Filing History:

15 out of 4,489

Pfizer Corporation

patents

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Biphenyl Compounds

Phenylpyridine Compounds

STING Modulators

Cyclin Dependent Kinase Inhibitors

Azalactam Compounds

HPK1 Inhibitors

Anti-Proliferative Agents

Cyclopentane-Based Modulators

Pyrimidine Derivatives

Dihydropyrrolopyrimidine Derivatives

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12655105 - Biphenyl and Phenylpyridine Compounds (2026-06-16),

2. 12378232 - Cyclin dependent kinase inhibitors (2025-08-05),

3. 12297190 - Modulators of STING (stimulator of interferon genes) (2025-05-13),

4. 11964978 - Modulators of STING (stimulator of interferon genes) (2024-04-23),

5. 11684616 - Azalactam compounds as HPK1 inhibitors (2023-06-27),

6. 11396512 - CDK2/4/6 inhibitors (2022-07-26),

7. 11220494 - Cyclin dependent kinase inhibitors (2022-01-11),

8. 11203594 - Anti-proliferative agents for treating PAH (2021-12-21),

9. 11142525 - Azalactam compounds as HPK1 inhibitors (2021-10-12),

10. 10968242 - Cyclopentane-based modulators of STING (stimulator of interferon genes) (2021-04-06),

11. 10800783 - CDK2/4/6 inhibitors (2020-10-13),

12. 10766884 - Cyclin dependent kinase inhibitors (2020-09-08),

13. 10538542 - Cyclopentane-based modulators of STING (stimulator of interferon genes) (2020-01-21),

14. 9758538 - Pyrimidine derivatives (2017-09-12),

15. 9260439 - Dihydropyrrolopyrimidine derivatives (2016-02-16),

Title: Innovations and Contributions of Mehran Jalaie

Introduction

Mehran Jalaie is a prominent inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. With a total of 14 patents to his name, Jalaie's work has had a substantial impact on medical research and treatment options.

Latest Patents

Among his latest patents are groundbreaking inventions such as Cyclin dependent kinase inhibitors, which relate to compounds of Formula (I). Additionally, he has developed modulators of STING (stimulator of interferon genes), which are compounds of the general formula (I). These inventions showcase his commitment to advancing medical science and improving therapeutic strategies.

Career Highlights

Mehran Jalaie is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to innovative drug development.

Collaborations

Throughout his career, Jalaie has worked alongside talented colleagues such as Ping Chen and Sajiv Krishnan Nair. These collaborations have fostered a dynamic environment for innovation and have led to the successful development of several important patents.

Conclusion

Mehran Jalaie's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations continue to shape the future of medical research and treatment.

Profile summary based on public USPTO records.